Group B Streptococcus: global incidence and vaccine development. - Wikidata - wikimedia - TriplyDB

Group B Streptococcus: global incidence and vaccine development.

Group B Streptococcus: global incidence and vaccine development.

http://www.wikidata.org/entity/Q36646803

about

Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection Intrapartum antibiotics for known maternal Group B streptococcal colonization Intrapartum antibiotics for known maternal Group B streptococcal colonization Intrapartum antibiotics for known maternal Group B streptococcal colonization Sortase A utilizes an ancillary protein anchor for efficient cell wall anchoring of pili in Streptococcus agalactiae Bacterial glycobiology: rhamnose-containing cell wall polysaccharides in Gram-positive bacteria A Model for Group B Streptococcus Pilus Type 1: The Structure of a 35-kDa C-Terminal Fragment of the Major Pilin GBS80 Structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infections The Crystal Structure Analysis of Group B Streptococcus Sortase C1: A Model for the “Lid” Movement upon Substrate Binding Structure ofStreptococcus agalactiaetip pilin GBS104: a model for GBS pili assembly and host interactions Understanding the regulation of Group B Streptococcal virulence factors Recent advances in understanding the molecular basis of group B Streptococcus virulence Adaptive response of Group B streptococcus to high glucose conditions: new insights on the CovRS regulation network Necrotizing fasciitis in captive juvenile Crocodylus porosus caused by Streptococcus agalactiae: an outbreak and review of the animal and human literature Prevention of neonatal group B streptococcus disease in the 21st century Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.Strains of Group B streptococci from septic patients induce platelet activation via Toll-like Receptor 2.The effect of intrapartum antibiotics on early-onset neonatal sepsis in Dhaka, Bangladesh: a propensity score matched analysis Bacterial meningitis in Malawian infants <2 months of age: etiology and susceptibility to World Health Organization first-line antibiotics.Group B streptococcus serotype prevalence in reproductive-age women at a tertiary care military medical center relative to global serotype distribution Computational bacterial genome-wide analysis of phylogenetic profiles reveals potential virulence genes of Streptococcus agalactiae.Novel targeted immunotherapy approaches for staphylococcal infection.Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroads Is administration of the HPV vaccine during pregnancy feasible in the future?Inhibition of IL-10 production by maternal antibodies against Group B Streptococcus GAPDH confers immunity to offspring by favoring neutrophil recruitment Emergence and global dissemination of host-specific Streptococcus agalactiae clones.Preliminary crystallographic study of the Streptococcus agalactiae sortases, sortase A and sortase C1.Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project.Association and virulence gene expression vary among serotype III group B streptococcus isolates following exposure to decidual and lung epithelial cells.Preterm infants have deficient monocyte and lymphocyte cytokine responses to group B streptococcus Understanding the molecular determinants driving the immunological specificity of the protective pilus 2a backbone protein of group B streptococcus Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis.Streptococcus agalactiae infection in zebrafish larvae Group B streptococci causing neonatal infections in barcelona are a stable clonal population: 18-year surveillance.Comparative genomics of the bacterial genus Streptococcus illuminates evolutionary implications of species groups Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study.Comparative genome analysis identifies two large deletions in the genome of highly-passaged attenuated Streptococcus agalactiae strain YM001 compared to the parental pathogenic strain HN016 A Safe and Stable Neonatal Vaccine Targeting GAPDH Confers Protection against Group B Streptococcus Infections in Adult Susceptible Mice.A Multi-Country Cross-Sectional Study of Vaginal Carriage of Group B Streptococci (GBS) and Escherichia coli in Resource-Poor Settings: Prevalences and Risk Factors

P2860

Q24187315-2FCFD2A4-6AAD-41DD-A8BD-1C8E6437DB4B Q24194038-2A3F5277-949C-40FD-A44A-B151ED49F84D Q24201721-4E262B98-0D49-46A5-8D47-11F91F407714 Q24240155-AB5AA6D3-0E64-4E7A-A8E3-46F3CFDB37A3 Q24651230-C9E79D66-FACE-4E69-B024-1EC599A59D17 Q26765815-388EF220-24FB-401A-81BD-4E719675E7D1 Q27667003-8FA5C404-EE36-4038-962D-8AC58934E560 Q27667893-7CABD798-0CAA-4EAF-9A75-353DDB394DF9 Q27675265-1C0F9B5A-3B67-4883-B0B1-ABDA757781FC Q27678225-DF482E05-A8C0-4C66-B8D0-F51885AE28E6 Q28237019-34D70C56-8D09-4C99-AC2D-828F3146FD22 Q28294474-525927E0-56C6-43BD-88E7-D0519A2D7A01 Q28486099-D839BD49-85B1-41B4-B045-FE8ECCC7F8AE Q28752181-DC3077C1-511C-44ED-863C-9163074B1DF1 Q29399413-F8DCC563-57F8-4124-80D5-79A611674BFF Q30431534-505BDFF8-AE7E-4A74-BD1D-1C09E5F00A3B Q33437089-7294865C-9588-4876-BC07-764D60537F41 Q33612719-C2D9F368-5D4B-47A7-A290-934601499AAB Q33630042-76C0F200-896F-4DD2-ADED-64FABD7C6D15 Q33755459-FED550AA-7AD6-4BE2-8E10-76DBF6561079 Q33869407-0AC4E15D-B0E3-4D82-A844-739217D40061 Q33910565-3F92C303-1F0D-4E73-8F08-27B1BA7568BC Q33916408-CA236F90-3C85-4BA1-B1CA-805BDD7BDCAB Q33920755-67C85FD2-A8F4-483D-87E9-F53B5F305AB2 Q34082651-569F7102-349B-461B-907B-8FE890D8A519 Q34100077-2CDDED5A-6BF8-4D61-B568-59200E2971B9 Q34109625-C7A74534-0510-4F3A-9B92-DA11F575F61D Q34112608-D7DCF15C-3D8A-4473-8184-9FA0268891D5 Q34252808-09B98983-8D86-449C-8073-C872FDEDD216 Q34596103-F6D8457C-19A7-4069-B4CE-E3FCAB65F2C0 Q34740184-69737CFD-AF82-4D63-8184-53FD3492A171 Q34795406-BA68129B-BA5B-4AEA-9633-4426325AFF39 Q34985330-1120E8F1-70DE-4DC0-9EDC-9E200173590B Q35122423-2EFBD91E-244C-483D-8FDE-C5C5208B82B9 Q35139753-291779E3-D123-4165-B57C-915A7EE2F532 Q35197598-6514CF21-94D7-47D4-9255-F3A1B2B8F724 Q35789964-D9BB3523-70CA-4E21-8F73-83148823F018 Q35832676-1545C1CC-F0F3-4130-A21D-3B253A17225C Q35870249-BA904F75-AC4A-4551-B3C5-B2048E58F25C Q35904763-98F2B121-42D0-43A4-8371-38B86CF655D3

P2860

Group B Streptococcus: global incidence and vaccine development.

http://www.wikidata.org/entity/Q36646803

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Group B Streptococcus: global incidence and vaccine development.

@ast

Group B Streptococcus: global incidence and vaccine development.

@en

type

label

Group B Streptococcus: global incidence and vaccine development.

@ast

Group B Streptococcus: global incidence and vaccine development.

@en

prefLabel

Group B Streptococcus: global incidence and vaccine development.

@ast

Group B Streptococcus: global incidence and vaccine development.

@en

P1433

Q36646803-7A0166E8-8C1E-4278-86E5-F4E6EB6DF3A5

P1476

Q36646803-B347470F-DFC1-43B2-A8DF-AE41508E241F

P2093

Q36646803-01A0F4A7-C881-49B4-B7BC-33F66E8D22FD

Q36646803-390B8D38-7DA8-4358-AE99-81ACB6099995

Q36646803-4DAFE14C-9D5B-4EC2-A5BA-B9EC646536AE

Q36646803-AB9B6C45-8528-4068-9907-C51A64031BD6

Q36646803-D975CF26-92BC-4EB6-BB70-F71C1A90853F

Q36646803-FB7FC86F-DDB6-4DD7-9CBD-A6A871B25A67

P2860

Q36646803-026CD0EA-540B-44E4-A7AE-3BCAA5106F0B

Q36646803-033964FC-047A-4CE0-B791-DEB9B617991A

Q36646803-05804BD8-84C1-4406-AB99-D222CF0FECB6

Q36646803-05D90905-E66D-4726-BB34-64CE6E9E7A37

Q36646803-07953D51-ED84-46B8-B0FB-1DEC468D91F3

Q36646803-0874FA5B-FD2F-404D-9856-746E126EDDA1

Q36646803-08B8FE35-FC75-45AA-98F2-F56313AFA593

Q36646803-0B4C9382-0733-42C1-B9C6-B65D0BF13804

Q36646803-12571474-3988-4C96-96A3-B4E670FDFEBF

Q36646803-17FD9373-4E2C-4351-B8F6-EA86A27028E0

P2888

Q36646803-E37B71AB-4090-4490-905D-F5E3890E5E79

P304

Q36646803-9F8075AE-CB32-4A0E-B4D8-FEC38758CDA9

P31

Q36646803-B99BC600-6304-4505-9055-C5D557CCAAF8

P356

Q36646803-CC7E6352-8FB1-4507-A977-C41AF1C8CDDC

P407

Q36646803-D7496970-484A-43E6-91A0-9915CBB4B52E

P433

Q36646803-8DBB0F3C-15D0-4D6B-A60F-C8CC1FAAE2A7

P478

Q36646803-2DDB1B3D-0BA6-4B19-921B-29E53371C4EC

P50

Q36646803-8819ABB8-8A9A-4647-8660-232C27B21DD0

P577

Q36646803-2E53737D-18E1-43C2-8811-CC4328319B82

P5875

Q36646803-01A7716D-9121-46F7-BDF7-1FEBA16BA3C2

P698

Q36646803-EFF18D33-A716-4D9E-A042-667EFA70D73F

P932

Q36646803-74167224-98D6-4D36-9F35-D0B89C5E1956

P356

P1433

Nature Reviews Microbiology

P1476

Group B Streptococcus: global incidence and vaccine development.

@en

P2093

Atul Kumar Johri

http://www.w3.org/2001/XMLSchema#string

Guido Grandi

http://www.w3.org/2001/XMLSchema#string

Lawrence C Paoletti

http://www.w3.org/2001/XMLSchema#string

Meenakshi Dua

http://www.w3.org/2001/XMLSchema#string

Philippe Glaser

http://www.w3.org/2001/XMLSchema#string

Puja Kumari Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae.

Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome"

Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease

Mechanism of action of the group A streptococcal C5a inactivator

Streptococcus agalactiae mastitis: a review

Invasion of brain microvascular endothelial cells by group B streptococci

Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

Pili in gram-positive pathogens

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

P2888

P304

932-942

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRMICRO1552

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6708117

http://www.w3.org/2001/XMLSchema#string

P698

17088932

http://www.w3.org/2001/XMLSchema#string

P932

2742968

http://www.w3.org/2001/XMLSchema#string